Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
U.S. stocks traded mostly higher, with the Nasdaq Composite gaining around 40 points on Wednesday.
Shares of Pfizer Inc. (NYSE:PFE) shares fell sharply during Wednesday’s session after the company provided FY24 guidance.
For FY24, the pharma giant expects revenue of $58.5 billion-$61.5 billion, including the expected contribution from the Seagen acquisition versus the consensus of $63.17 billion. The company forecasts FY24 adjusted diluted EPS guidance of $2.05-$2.25, including the expected impact of the Seagen acquisition, compared to the consensus of $3.17.
Pfizer shares tumbled 8.8% to $26.07 on Wednesday.
Here are some other big stocks recording losses in today’s session.
Now Read This: Bitcoin, Ethereum Fall Ahead Of Fed Decision; Bonk Becomes Top Loser